双特异性抑制剂向了三糖生物合成途径中的酶
Yitong Chen1, Liu Tang1, Zhiyang Jiang2
1Ministry of Agriculture Key Laboratory for Crop Pest Monitoring and Green Control, College of Plant Protection, China Agricultural University, Beijing 100193, China.
Journal of agricultural and food chemistry
|December 21, 2023
概括
研究人员在Magnaporthe oryzae中发现了A1-4,一种新型的双重特异性杀菌剂,向三六酸盐合成酶 (TPS) 和三六酸盐酸酶 (TPP). 这种抑制剂显示出开发更安全的杀菌剂来对抗抗性的前景.
科学领域:
- 生物化学 生物化学
- 植物病理学 植物病理学
- 药用化学 医学化学
背景情况:
- 抗真菌杀菌剂耐药性需要具有独特作用模式的新型化合物.
- 动物中没有三糖生物合成酶,三糖-6-酸盐合成酶 (TPS) 和三糖-6-酸盐酸酶 (TPP),这使得它们成为安全的杀菌剂标.
- 麦格纳波特 (Magnaporthe oryzae) 对农业构成重大威胁,需要有效的控制策略.
研究的目的:
- 发现和描述一种新的双特异性抑制剂,针对Magnaporthe oryzae中的TPS和TPP酶.
- 评估已识别的抑制剂对M. oryzae毒性的有效性,并了解其作用机制.
主要方法:
- 使用虚拟查和表面等离子体共振 (SPR) 来识别潜在的抑制剂.
- 在体外酶抑制试验中,使用纯化的MoTps1和MoTps2-TPP进行了测试.
- 生物活性测定评估了M. oryzae的毒性和虫形态.
- 用/交换质谱法 (HDX-MS) 来研究抑制剂-对象相互作用.
主要成果:
- 鉴定出A1-4是一种双特异性抑制剂,与MoTps1和MoTps2-TPP相互作用.
- 在体外,A1-4有效抑制了TPS和TPP的酶活性.
- 生物测试表明,A1-4抑制了M. oryzae的毒性,并诱导状细胞醇聚合,这是MoTps2相关的表型.
- HDX-MS数据表明A1-4与TPS和TPP的基质结合口袋结合.
结论:
- A1-4是一种强大的打击化合物,在M. oryzae的三糖生物合成途径中对关键酶具有双重目标特异性.
- 发现A1-4为开发新型,更安全的杀菌剂提供了有希望的基础,降低了耐药性发展风险.
- 针对TPS和TPP同时提供了一种强大的策略来控制M. oryzae和潜在的其他真菌病原体.
相关概念视频
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
The Electron Transport Chain
16.8K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


